Decode Civils CAShorts
Sci-TechPrelimsGS3

Bundibugyo Ebola: WHO expects Ervebo trial in DR Congo this month

By CAShorts DeskPublished Source: The Hindu (AFP), 14 October 2026; WHO SAGE meeting highlights, 5-8 October 2026; WHO Ebola fact sheet

Bundibugyo Ebola: WHO expects Ervebo trial in DR Congo this month
Illustration (AI-generated)

The World Health Organization's vaccine advisers said on 13 October 2026 that a large human trial of Ervebo, an Ebola vaccine approved only against the Ebola virus species, should begin in the Democratic Republic of the Congo this month. It will test whether Ervebo also protects against the Bundibugyo virus, whose outbreak there has passed 9,000 cases and 4,000 deaths.

Syllabus: Prelims · Science & Technology; GS3 · Science & Technology; GS2 · Health, Education & Human Resources

Why this matters for UPSC

GS2 health and international institutions, and GS3 science: Prelims can ask about Ebola disease, its virus species, approved vaccines and how WHO declares a PHEIC under the International Health Regulations (2005).

Why it matters

For families in eastern Congo, the outbreak has no vaccine and no specific medicine, so each new case can only be met with isolation, supportive care and contact tracing. A trial that shows Ervebo works against Bundibugyo would let an already licensed vaccine be used against it, starting with the contacts of the sick and the nurses who treat them. If it fails, the Oxford and Moderna candidates become the main hope. The larger lesson is that a vaccine made for one virus species cannot be assumed to cover its cousins: only a proper trial, run inside a conflict zone, can tell.

Prelims pointers

  • Ebola transmission: fruit bats of the family Pteropodidae are thought to be natural hosts; people cannot transmit the disease before symptoms appear.
  • Incubation period of Ebola disease is 2 to 21 days, so contacts are monitored for 21 days.
  • Ebola case fatality averages about 50%, ranging from 25% to 90% in past outbreaks, per WHO.
  • First Ebola outbreaks, 1976: Yambuku near the Ebola River in today's DRC (Ebola virus) and Nzara in today's South Sudan (Sudan virus).
  • Four Orthoebolavirus species are known to cause disease in humans, per WHO: Ebola, Sudan, Bundibugyo and Taï Forest viruses.
  • WHO prequalification of Ervebo on 12 November 2019 was the first for any Ebola vaccine.
  • Ervebo for outbreaks comes from the International Coordinating Group on Vaccine Provision stockpile; preventive vaccination of health workers is requested through Gavi.
  • International Health Regulations (2005) are legally binding on 197 countries, including all 194 WHO Member States; Article 12 governs PHEIC determination.

Practise a UPSC-style question

With reference to Ebola disease, consider the following statements:

1. It is caused by viruses of the genus Orthoebolavirus, which belongs to the family Filoviridae.

2. Fruit bats of the family Pteropodidae are thought to be natural hosts of the virus.

3. An infected person can transmit the disease during the incubation period, before any symptoms appear.

Which of the statements given above are correct?

  1. (a) 1 and 2 only
  2. (b) 2 and 3 only
  3. (c) 1 and 3 only
  4. (d) 1, 2 and 3
Show the answer

Answer: (a) 1 and 2 only

Answer: (a) 1 and 2 only. The virus family and the bat host are right; spread before symptoms is not.

Statement 1: correct. WHO places the Ebola-causing viruses in the genus Orthoebolavirus of the family Filoviridae.

Statement 2: correct. WHO says fruit bats of the Pteropodidae family are thought to be the natural hosts of Orthoebolavirus.

Statement 3: incorrect. WHO states people cannot transmit Ebola before they have symptoms; they stay infectious while the virus is in their blood.

Eliminate: statement 3 is wrong because Ebola spreads only after symptoms begin. Out: (b), (c), (d).

Trap: Sounds right. Many infections such as influenza spread before symptoms, so a student may assume Ebola does too; WHO says it does not.

Remember: Ebola: Filoviridae family, fruit bat host, infectious only once symptoms start.

More from the 15 October 2026 edition

All stories of 15 October 2026

More Sci-Tech current affairs